NTI Recorded Session NTI23330
Author(s): Rachael Georges, Geralyn Esworthy
Contact Hours 1.25
CERP A 1.25
Expires Dec 31, 2025
Topics: Medication Management
Population: Adult
Role: Staff
Required reading for all learners: Implicit Bias impacts patient outcomes
This session presents an advanced overview of dexmedetomidine (Precedex) and its use in the Progressive Care and Stepdown units. Dexmedetomidine is a relatively selective alpha2-adrenergic agonist indicated for use outside of the ICU for improved tolerance of noninvasive respiratory support, alcohol/opiate withdrawal- adjunctive therapy and ICU transfer on low-dose therapy when ICU admission criteria are otherwise no longer met.Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.
AccreditationAmerican Association of Critical-Care Nurses is accredited as a provider of
nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for
{contactHours} contact hours.
The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.
Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.
Refund PolicyContinuing Education Activities are nonrefundable.